Hemothorax after fetal pleural effusion-thoracoamniotic shunting procedure due to transient myeloproliferative disorder

IF 0.1 Q4 OBSTETRICS & GYNECOLOGY

Case Reports in Perinatal Medicine Pub Date : 2022-01-01 DOI:10.1515/crpm-2021-0032

Y. Iwahata, H. Iwahata, J. Hasegawa, C. Homma, Y. Nishimura, H. Kondo, N. Suzuki

引用次数: 0

Abstract

Abstract Objectives To present a case of fetal hemothorax after two times of thoracoamniotic shunting (TAS) performed to pleural effusion with hydrops fetalis, resulting in non-reassuring fetal status due to hemothorax. Case presentation This is a case of bilateral pleural effusion with hydrops fetalis and polyhydramnios at 32 weeks gestation, in which unilateral fetal TAS was performed twice, resulting in non-reassuring fetal status due to hemothorax. After delivery, the infant was diagnosed with trisomy 21 and transient myeloproliferative disorder (TMD) with disseminated intravascular coagulation and congenital systemic lymphangiopathy. Conclusions In conclusion, since TAM case do not always show hemothrax, TAM is not inhibited but technical carefulness should be necessary.

查看原文本刊更多论文

胎儿胸腔积液-胸羊膜分流术后因短暂性骨髓增殖性疾病引起的血胸

【摘要】目的介绍一例因胸腔积液合并胎儿积液行两次胸羊膜分流术(TAS)导致胎儿血胸状态不稳定的病例。病例介绍:这是一例妊娠32周双侧胸腔积液合并胎水和羊水过多的病例，其中单侧胎儿TAS两次，由于血胸导致胎儿状态不稳定。出生后，婴儿被诊断为21三体和短暂性骨髓增生性疾病(TMD)，并伴有弥漫性血管内凝血和先天性全身性淋巴管病。结论由于TAM病例并不总是表现为血液，TAM不应被抑制，但技术上应谨慎。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Case Reports in Perinatal Medicine OBSTETRICS & GYNECOLOGY-

自引率

0.00%

发文量

期刊介绍： Case Reports in Perinatal Medicine is a double-blind peer-reviewed journal. The objective of the new journal is very similar to that of JPM. In addition to evidence-based studies, practitioners in clinical practice esteem especially exemplary reports of cases that reveal specific manifestations of diseases, its progress or its treatment. We consider case reports and series to be brief reports describing an isolated clinical case or a small number of cases. They may describe new or uncommon diagnoses, unusual outcomes or prognosis, new or infrequently used therapies and side effects of therapy not usually discovered in clinical trials. They represent the basic concept of experiences for studies on representative groups for further evidence-based research. The potential roles of case reports and case series are: Recognition and description of new diseases Detection of drug side effects (adverse or beneficial) Study of mechanisms of disease Medical education and audit Recognition of rare manifestations of disease.